AR129986A1 - COMPOSITIONS AND PHARMACEUTICAL FORMS FOR THE TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASM - Google Patents
COMPOSITIONS AND PHARMACEUTICAL FORMS FOR THE TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASMInfo
- Publication number
- AR129986A1 AR129986A1 ARP230101911A ARP230101911A AR129986A1 AR 129986 A1 AR129986 A1 AR 129986A1 AR P230101911 A ARP230101911 A AR P230101911A AR P230101911 A ARP230101911 A AR P230101911A AR 129986 A1 AR129986 A1 AR 129986A1
- Authority
- AR
- Argentina
- Prior art keywords
- hpv
- compositions
- treatment
- pharmaceutical forms
- compound
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 208000009608 Papillomavirus Infections Diseases 0.000 title 1
- 208000035269 cancer or benign tumor Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002015 acyclic group Chemical group 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una sal farmacéuticamente aceptable de un fosforamidato de nucleótido acíclico para tratar el VPH y afecciones relacionadas, incluida la neoplasia, así como composiciones farmacéuticas, formas mórficas y formas de dosificación de las mismas. Reivindicación 1: Un compuesto de la fórmula: (1). Reivindicación 2: Un compuesto de la fórmula: (2) o una sal farmacéuticamente aceptable de este. Reivindicación 3: Un compuesto de la fórmula: (3) o una sal farmacéuticamente aceptable de este.A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate for treating HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morpholine forms and dosage forms thereof. Claim 1: A compound of the formula: (1). Claim 2: A compound of the formula: (2) or a pharmaceutically acceptable salt thereof. Claim 3: A compound of the formula: (3) or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063400661P | 2020-08-24 | 2020-08-24 | |
| US202063412143P | 2020-09-30 | 2020-09-30 | |
| US202263391283P | 2022-07-21 | 2022-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR129986A1 true AR129986A1 (en) | 2024-10-23 |
Family
ID=93378780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230101911A AR129986A1 (en) | 2020-08-24 | 2023-07-21 | COMPOSITIONS AND PHARMACEUTICAL FORMS FOR THE TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASM |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR129986A1 (en) |
-
2023
- 2023-07-21 AR ARP230101911A patent/AR129986A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551762A1 (en) | Peptide macrocycles against acinetobacter baumannii | |
| CL2022001529A1 (en) | New methylquinazolinone derivatives | |
| CL2019002204A1 (en) | HIV inhibitor compounds. | |
| JOP20210319A1 (en) | pyrrolidine compounds | |
| AR111495A1 (en) | FUSIONED IMIDAZO-PIPERIDINE COMPOUNDS AS JAK INHIBITORS | |
| EA202190854A1 (en) | HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | |
| EA202193015A1 (en) | CDK INHIBITORS | |
| EA202092168A1 (en) | APPLICATION OF FAVIPIRAVIR IN THE TREATMENT OF CORONAVIRUS INFECTION | |
| MX384868B (en) | COMPOSITIONS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY. | |
| UY38559A (en) | HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | |
| AR119174A1 (en) | HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | |
| MX2021015056A (en) | Pyrrolopyrimidine compound and use thereof. | |
| CO2025001854A2 (en) | Compositions and pharmaceutical forms for the treatment of HPV infection and HPV-induced neoplasia | |
| BR112022010181A2 (en) | TRIHETEROCYCLIC COMPOUND AS A JAK INHIBITOR AND USE OF IT | |
| MX2024002538A (en) | Use of ezh2 inhibitor in preparation of drug for treating t-cell lymphoma. | |
| CO2024000221A2 (en) | Substituted pyrimidinyl-pyrazoles as cdk2 inhibitors | |
| MX2022012881A (en) | Inhibitors of human immunodeficiency virus replication. | |
| AR129986A1 (en) | COMPOSITIONS AND PHARMACEUTICAL FORMS FOR THE TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASM | |
| AR126892A1 (en) | SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS | |
| CO2022006965A2 (en) | egfr inhibitors | |
| CL2024001073A1 (en) | Inhibitors of human immunodeficiency virus replication | |
| MX2024010402A (en) | Emopamil-binding protein inhibitors and uses thereof | |
| CO2021008891A2 (en) | Conjugates of exon skipping oligomers for muscular dystrophy | |
| CO2019014516A2 (en) | A pharmaceutical nanosuspension for the treatment of hiv infection | |
| EA202290157A1 (en) | TERTIARY AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTION |